EyePoint Pharmaceuticals Inc. buy Robert W. Baird
Start price
08.05.24
/
50%
€10.75
Target price
08.05.25
€35.34
Performance (%)
-21.30%
Price
04.06.24
€8.46
Summary
This prediction is currently active. The price of EyePoint Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.30%. This prediction currently runs until 08.05.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| EyePoint Pharmaceuticals Inc. | -16.690% |
| iShares Core DAX® | -1.042% |
| iShares Nasdaq 100 | -1.361% |
| iShares Nikkei 225® | -0.044% |
| iShares S&P 500 | -0.480% |
Comments by Robert_W__Baird for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $46.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Robert_W__Baird for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
20.04.23
20.04.23
-
20.04.24
20.04.24
205.00%
21.04.24
21.04.24
